Hot Features
Premium
Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Ambrx Biopharma Inc | AMAM | NYSE | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 10.13 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 10.13 |
| Trades | Shares Traded | Average Volume |
|---|---|---|
| 0 | 0 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 10.13 | USD |
Ambrx Biopharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 633.53M | - | - | - | 66.67 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ambrx Biopharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/12/2023 | 15:20 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in.. |
| 10/12/2023 | 15:15 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in.. |
| 10/12/2023 | 15:10 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in.. |
| 10/12/2023 | 15:05 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in.. |
| 10/12/2023 | 05:04 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/10/2023 | 15:49 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/10/2023 | 10:35 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 10/06/2023 | 15:07 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/25/2023 | 16:24 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 7/07/2023 | 15:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AMAM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 18.00 | 22.8702 | 0.38 | 5.29 | 1,163,517 | -7.87 | -43.72% |
| 5 Years | 18.00 | 22.8702 | 0.38 | 5.29 | 1,163,517 | -7.87 | -43.72% |
Ambrx Biopharma Description
| Ambrx Biopharma Inc is a clinical-stage biologics company focused on discovering and developing a novel class of engineered precision biologics (EPBs) using its proprietary expanded genetic code technology platform that allows incorporating synthetic amino acids (SAAs) into proteins within living cells. Its product pipeline includes ARX788, ARX517, ARX305 among others. |
